Follow
Yoel Zacarías Betancor
Yoel Zacarías Betancor
Other namesYoel Z. Betancor
PhD student in Molecular Medicine, University of Santiago de Compostela
Verified email at rai.usc.es
Title
Cited by
Cited by
Year
Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy
M Pérez-Martelo, A González-García, Y Vidal-Ínsua, C Blanco-Freire, ...
Scientific Reports 12 (1), 6893, 2022
102022
MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles
M Santamarina-García, J Brea-Iglesias, JB Bramsen, M Fuentes-Losada, ...
Iscience 26 (3), 2023
12023
Clinical outcomes of immunotherapy-based first-line regimens in advanced Renal Cell Carcinoma–the Onco-CHUS experience
UA Herranz, N Fernandez-Diaz, J Garcia-Gonzalez, V Cebey-Lopez, ...
European Urology Open Science 57, S233, 2023
2023
Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the …
M Ferreiro-Pantín, U Anido-Herranz, YZ Betancor, V Cebey-López, ...
ESMO open 8 (4), 101611, 2023
2023
Use of immunotherapy-based combos in advanced renal cell carcinoma in a Galician center.
U Anido, J García González, V Cebey, M Mateos González, M Touris, ...
Journal of Clinical Oncology 41 (16_suppl), e16542-e16542, 2023
2023
A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma
YZ Betancor, M Ferreiro-Pantin, U Anido-Herranz, M Fuentes-Losada, ...
medRxiv, 2023.12. 03.23299342, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–6